BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30149879)

  • 1. Balancing the Economics and Ethics of Personalised Oncology.
    Flaum N; Hall P; McCabe C
    Trends Cancer; 2018 Sep; 4(9):608-615. PubMed ID: 30149879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budget impact and cost-effectiveness: can we afford precision medicine in oncology?
    Doble B
    Scand J Clin Lab Invest Suppl; 2016; 245():S6-S11. PubMed ID: 27426412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Medicine in Oncology II: Economics of Targeted Agents and Immuno-Oncology Drugs.
    Huntington SF; Davidoff AJ; Gross CP
    J Clin Oncol; 2020 Feb; 38(4):351-358. PubMed ID: 31804866
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
    Gupta S; Smith TR; Broekman ML
    J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical Hurdles in the Prioritization of Oncology Care.
    de Groot F; Capri S; Castanier JC; Cunningham D; Flamion B; Flume M; Herholz H; Levin LÅ; Solà-Morales O; Rupprecht CJ; Shalet N; Walker A; Wong O
    Appl Health Econ Health Policy; 2017 Apr; 15(2):119-126. PubMed ID: 27766548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics.
    Fiore RN; Goodman KW
    Curr Opin Oncol; 2016 Jan; 28(1):83-7. PubMed ID: 26569425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalised medicine in paediatric oncology: Ethical practice outside the clinical trial framework?
    Hansford JR
    J Paediatr Child Health; 2019 Jan; 55(1):10-12. PubMed ID: 30499210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ethics and economics in oncology].
    Winkler E; Schildmann J
    Onkologie; 2011; 34 Suppl 1():1. PubMed ID: 21389760
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of cancer care: ethical considerations for the practicing oncologist.
    Jagsi R; Sulmasy DP; Moy B
    Am Soc Clin Oncol Educ Book; 2014; ():e146-9. PubMed ID: 24857095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer care, money, and the value of life: whose justice? Which rationality?
    Sulmasy DP
    J Clin Oncol; 2007 Jan; 25(2):217-22. PubMed ID: 17210943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partnering with patients in translational oncology research: ethical approach.
    Mamzer MF; Duchange N; Darquy S; Marvanne P; Rambaud C; Marsico G; Cerisey C; Scotté F; Burgun A; Badoual C; Laurent-Puig P; Hervé C
    J Transl Med; 2017 Apr; 15(1):74. PubMed ID: 28390420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allocation of public sources in oncology: which role can ethics play?
    Bernardi A; Jirillo A; Pegoraro R; Bonavina MG
    Ann Oncol; 2007 Jul; 18(7):1129-31. PubMed ID: 17675393
    [No Abstract]   [Full Text] [Related]  

  • 14. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine: what's all the fuss about?
    Barker R
    Scand J Clin Lab Invest Suppl; 2016; 245():S2-5. PubMed ID: 27542001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The shortage of essential chemotherapy drugs in the United States.
    Gatesman ML; Smith TJ
    N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethics of Pharma Clinical Trials in the Era of Precision Oncology.
    Turner JH
    Cancer Biother Radiopharm; 2021 Feb; 36(1):1-9. PubMed ID: 32935997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis in oncology.
    Earle CC; Coyle D; Evans WK
    Ann Oncol; 1998 May; 9(5):475-82. PubMed ID: 9653486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The science of precision prevention of cancer.
    Vineis P; Wild CP
    Lancet Oncol; 2017 Aug; 18(8):997-998. PubMed ID: 28759370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.